Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Application | Utility: Single Immunoglobulin Interleukin-1 Receptor Related (SIGIRR) Variants And Uses Thereof Filling date: 12 Sep 2025 Issue date: 11 Mar 2021 |
Grant | Utility: Human antibodies to S. aureus hemolysin A toxin Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Anti-TMPRSS2 antibodies and antigen-binding fragments Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Anti-PCSK9 antibodies Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Method of using mouse having a humanized cluster of differentiation 47 gene Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Anti-MUC16 antibodies Filling date: 12 Sep 2025 Issue date: 9 Mar 2021 |
Application | Utility: TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA Filling date: 12 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: METHOD OF AVERTING OPIOID ADDICTION Filling date: 12 Sep 2025 Issue date: 4 Mar 2021 |
Grant | Utility: Non-human animals expressing humanized CD3 complex Filling date: 12 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Methods for increasing lean body mass with resistance training and a GDF8 inhibitor that is an anti-GDF8 antibody Filling date: 12 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (SIT) Filling date: 12 Sep 2025 Issue date: 2 Mar 2021 |
Application | Utility: GENETICALLY MODIFIED T CELL RECEPTOR MICE Filling date: 12 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: HUMAN ANTIBODIES TO BET V 1 AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: FORMULATION OPTIMIZATION FOR BISPECIFIC ANTIBODIES Filling date: 12 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES Filling date: 12 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 25 Feb 2021 |
Grant | Utility: Taurine supplemented cell culture medium and methods of use Filling date: 12 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Compositions and methods for reducing bioburden in chromatography Filling date: 12 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Methods of treating PRLR positive breast cancer Filling date: 12 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Compositions for the treatment of rheumatoid arthritis and methods of using same Filling date: 12 Sep 2025 Issue date: 23 Feb 2021 |
Application | Utility: Multispecific Antigen-Binding Molecules for Cell Targeting and Uses Thereof Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: HIGH CONCENTRATION ANTI-C5 FORMULATIONS Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Grant | Utility: Sterilisation method Filling date: 12 Sep 2025 Issue date: 16 Feb 2021 |
Application | Utility: Anti-CTLA-4 Antibodies and Uses Thereof Filling date: 12 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: NOVEL ANTIGEN BINDING MOLECULE FORMATS Filling date: 12 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST Filling date: 12 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R ANTAGONIST Filling date: 12 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: STEROIDS AND PROTEIN-CONJUGATES THEREOF Filling date: 12 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS FOR QUANTITATING INDIVIDUAL ANTIBODIES FROM A MIXTURE Filling date: 12 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN LOCUS Filling date: 12 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: MEDICAL DEVICE PACKAGING AND RELATED METHODS Filling date: 12 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST Filling date: 12 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: Methods for Quantifying IL-33 Filling date: 12 Sep 2025 Issue date: 4 Feb 2021 |
Grant | Utility: Sterilisation method Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Dual-column LC-MS system and methods of use thereof Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: ADAM6 mice Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: ADAM6 mice Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Radiolabeled anti-LAG3 antibodies for immuno-PET imaging Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 12 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN Filling date: 12 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATIONS AND METHODS OF USE Filling date: 12 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: AFFINITY CHROMATOGRAPHY-COUPLED NATIVE MASS SPECTROMETRY FOR ANTIBODY ANALYSIS Filling date: 12 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: Anti-PfRH5 Antibodies and Antigen-Binding Fragments Thereof Filling date: 12 Sep 2025 Issue date: 28 Jan 2021 |
Grant | Utility: Genetic modification of rats Filling date: 12 Sep 2025 Issue date: 19 Jan 2021 |
Grant | Utility: Production of fertile XY female animals by silencing of genes on the Y chromosome Filling date: 12 Sep 2025 Issue date: 19 Jan 2021 |
Application | Utility: Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) Inhibitors Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: Recombinant Cell Surface Capture Proteins Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: METHODS AND COMPOSITIONS COMPRISING REDUCED LEVEL OF HOST CELL PROTEINS Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: MODELS OF TAUOPATHY Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Showing 250 to 300 of 704 patents.